Finally, to assess the extent of cell death in vivo, B16 melanoma cells were injected subcutaneously (s.c.)into the flank of C57Bl/6 mice, and 6 days later, MLKL- and tBid-mRNA was administered into the tumor (mRNA injection followed by electroporation). The gene discussed is MLKL; the disease is melanoma.